AL
Alector, Inc.
ALEC · NASDAQ
$2.04 -7.08% (-$0.15)
1M -0.49%
Market Cap $225.9M
P/E Ratio -
Div. Yield -
ROE 531.04%
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/S 16.30x
EV/FFO N/A
P/E N/A
Growth
0 /100
Declining Book val. growth 47.72%
Rev. growth 46.00%
FCF growth N/A
Profitability
0 /100
Weak Op. margin 914.56%
Gross margin 360.92%
FCF margin 1,142.55%
Quality
1 /100
Poor ROA 58.10%
ROIC 67.73%
Asset turnover 0.07x
Debt
100 /100
Low Current ratio 5.26x
Net debt/EBITDA N/A
Debt/Equity N/A
Stability
53 /100
Moderate EPS volatility 17.08%
Beta 0.58x
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na ALEC
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Arnon Rosenthal
Employees
103
Headquarters
South San Francisco
Nadcházející události
05 LIS
Earnings
Upcoming earnings report